Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 431Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Aspen Pharmacare Holdings

02 1Strides Pharma Science

03 1Adcock Ingram

04 4Aurobindo Pharma Limited

05 1Austell Laboratories

06 3Cipla

07 7Cipla Medpro South Africa

08 6Emcure Pharmaceuticals

09 2GSK

10 8Hetero Drugs

11 1Kiara Health

12 2Laurus Generics

13 2Laurus Labs

14 6Macleods Pharmaceuticals Limited

15 1Micro Labs Limited

16 1Novagen Pharma

17 1Orbit Lifescience

18 1Pfizer Inc

19 1Shanghai Desano Bio-Pharmaceutical

20 2Sun Pharmaceutical Industries Limited

21 8Viatris

22 26ViiV Healthcare

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BioAsia
Not Confirmed

Dolutegravir

Brand Name : Gradovir

Dosage Form : TAB

Dosage Strength : 50mg

Packaging : 30X1mg

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

Aspen API Comapny Banner

02

arrow
BioAsia
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info :

Registration Country : India

Dolutegravir Sodium

Brand Name :

Dosage Form : Tablet

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

03

arrow
BioAsia
Not Confirmed

Dolutegravir

Brand Name : Vulante

Dosage Form : FCT

Dosage Strength : 50mg

Packaging : 30X1mg

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

Aspen API Comapny Banner

04

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR SODIUM

Brand Name : DOLUTEGRAVIR SODIUM

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 208355

Regulatory Info :

Registration Country : USA

blank

05

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR SODIUM

Brand Name : DOLUTEGRAVIR SODIUM

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 209658

Regulatory Info :

Registration Country : USA

blank

06

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR SODIUM

Brand Name : DOLUTEGRAVIR SODIUM

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 210812

Regulatory Info :

Registration Country : USA

blank

07

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE

Brand Name : DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE

Dosage Form : TABLET

Dosage Strength : EQ 50MG BASE; 300MG; 25MG

Packaging :

Approval Date :

Application Number : 212527

Regulatory Info :

Registration Country : USA

blank

08

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE

Brand Name : DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG/300MG/300MG

Packaging :

Approval Date :

Application Number : 211868

Regulatory Info :

Registration Country : USA

blank

09

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR

Brand Name : DOLUTEGRAVIR

Dosage Form : FILM;ORAL

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number : 215319

Regulatory Info :

Registration Country : USA

blank

10

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR

Brand Name : DOLUTEGRAVIR

Dosage Form : FILM;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number : 215319

Regulatory Info :

Registration Country : USA

blank

11

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE

Brand Name : DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG; 300MG;300MG

Packaging :

Approval Date :

Application Number : 210787

Regulatory Info :

Registration Country : USA

blank

12

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR SODIUM

Brand Name : DOLUTEGRAVIR SODIUM

Dosage Form : TABLET; ORAL

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 210963

Regulatory Info :

Registration Country : USA

blank

13

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE

Brand Name : DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG/300MG/300MG

Packaging :

Approval Date :

Application Number : 210796

Regulatory Info :

Registration Country : USA

blank

14

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR SODIUM

Brand Name : DOLUTEGRAVIR SODIUM

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE

Packaging :

Approval Date :

Application Number : 214397

Regulatory Info :

Registration Country : USA

blank

15

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR SODIUM

Brand Name : DOLUTEGRAVIR SODIUM

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date :

Application Number : 214397

Regulatory Info :

Registration Country : USA

blank

16

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR SODIUM

Brand Name : DOLUTEGRAVIR SODIUM

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 50MG BASE

Packaging :

Approval Date :

Application Number : 214397

Regulatory Info :

Registration Country : USA

blank

17

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR SODIUM

Brand Name : DOLUTEGRAVIR SODIUM

Dosage Form : TABLET; ORAL SUSPENSION

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number : 214566

Regulatory Info :

Registration Country : USA

blank

18

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR SODIUM

Brand Name : DOLUTEGRAVIR SODIUM

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 212179

Regulatory Info :

Registration Country : USA

blank

19

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE

Brand Name : DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE

Dosage Form : TABLET; ORAL

Dosage Strength : 50MG/300MG/300MG

Packaging :

Approval Date :

Application Number : 212303

Regulatory Info :

Registration Country : USA

blank

20

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE

Brand Name : DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG; 300MG; 300MG

Packaging :

Approval Date :

Application Number : 213556

Regulatory Info :

Registration Country : USA

blank

21

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR SODIUM

Brand Name : DOLUTEGRAVIR SODIUM

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 209602

Regulatory Info :

Registration Country : USA

blank

22

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE

Brand Name : DOLUTEGRAVIR, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG;300MG;300MG

Packaging :

Approval Date :

Application Number : 209670

Regulatory Info :

Registration Country : USA

blank

23

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR SODIUM

Brand Name : TIVICAY

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 50MG BASE

Packaging :

Approval Date : 2013-08-12

Application Number : 204790

Regulatory Info : RX

Registration Country : USA

blank

24

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR SODIUM

Brand Name : TIVICAY

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2016-06-09

Application Number : 204790

Regulatory Info : DISCN

Registration Country : USA

blank

25

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR SODIUM

Brand Name : TIVICAY

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2016-06-09

Application Number : 204790

Regulatory Info : DISCN

Registration Country : USA

blank

26

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Brand Name : TRIUMEQ

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 600MG BASE;EQ 50MG BASE;300MG

Packaging :

Approval Date : 2014-08-22

Application Number : 205551

Regulatory Info : RX

Registration Country : USA

blank

27

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE

Brand Name : JULUCA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 50MG BASE;EQ 25MG BASE

Packaging :

Approval Date : 2017-11-21

Application Number : 210192

Regulatory Info : RX

Registration Country : USA

blank

28

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR SODIUM; LAMIVUDINE

Brand Name : DOVATO

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 50MG BASE;300MG

Packaging :

Approval Date : 2019-04-08

Application Number : 211994

Regulatory Info : RX

Registration Country : USA

blank

29

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

DOLUTEGRAVIR SODIUM

Brand Name : TIVICAY PD

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : EQ 5MG BASE

Packaging :

Approval Date : 2020-06-12

Application Number : 213983

Regulatory Info : RX

Registration Country : USA

blank

30

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Brand Name : TRIUMEQ PD

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : EQ 60MG BASE;EQ 5MG BASE;30MG

Packaging :

Approval Date : 2022-03-30

Application Number : 215413

Regulatory Info : RX

Registration Country : USA

blank